跳至主要内容
临床试验/DRKS00034742
DRKS00034742尚未招募Unknown

Vitamin supplementation in cystic fibrosis in the era of modulators: the impact of vitamin K2 on cardio-metabolic health – a randomised double-blind placebo-controlled trial

Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 2024年8月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
13 Years 至 one(—)
性别
All

入选标准

  • Diagnosed CF, receiving triple therapy (age> 12 years, genotype concordant with the ministerial program), pancreatic insufficiency, fat-soluble vitamin supplementation, and willingness to participate in the study.

排除标准

  • Liver cirrhosis, organ transplantation, cachexia, other concomitant gastrointestinal CF non-related diseases interfering with digestion and absorption, diagnosed chronic severe diseases, vitamin MK-7 supplements in the last 3 months, lack of nutritional supervision by a dietician.

研究者

发起方
Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences

相似试验